Interplay Between BDNF/Trkb Signalling and Gabaergic Inhibition in the Visual Cortex of Mice

Interplay Between BDNF/Trkb Signalling and Gabaergic Inhibition in the Visual Cortex of Mice

Interplay between BDNF/TrkB signalling and GABAergic inhibition in the visual cortex of mice Dissertation Zur Erlangung des Grades Doktor der Naturwissenschaften Am Fachbereich Biologie Der Johannes Gutenberg-Universität Mainz vorgelegt von Daniele Marongiu geb. am 16.07.1985 in Italien Mainz, 2013 Tag der mündlichen Prüfung: 24.September.2013 Table of Contents Table of Contents Table of Contents ....................................................................................................................... 1 List of Figures ............................................................................................................................ 4 Abstract ...................................................................................................................................... 6 Zusammenfassung...................................................................................................................... 8 Abbreviations .......................................................................................................................... 10 1. Introduction ........................................................................................................................ 13 1.1. The mouse visual system ............................................................................................ 13 1.1.1. Structure and circuits of the primary visual cortex .......................................... 15 1.2. Plasticity in the visual cortex ...................................................................................... 16 1.3. The GABAergic system .............................................................................................. 18 1.3.1. GABA (γ-amminobutyric acid) ...................................................................... 18 1.3.2. GABA receptors............................................................................................... 19 1.3.3. The role of Chloride Transporters on GABAergic function ............................ 20 1.4. Brain Derived Neurotrophic Factor (BDNF) ............................................................. 22 1.4.1. BDNF receptors and signaling pathways ......................................................... 23 1.4.2. Effect of BDNF on GABAergic and glutamatergic synaptic transmission ..... 26 1.4.3. BDNF and long term plasticity ........................................................................ 27 1.4.4. TrkB receptor agonists and antagonists ........................................................... 28 1.5. Flavonoids and 7,8-Dihydroxyflavone ....................................................................... 28 1.6. Interplay between BDNF and GABAergic inhibition (in the regulation of visual cortical plasticity) ...................................................................................................... 30 1.7. Focal laser lesion in the visual cortex ......................................................................... 33 1.8. Objectives of the study ............................................................................................... 34 2. Materials and Methods ....................................................................................................... 35 2.1. Animals ....................................................................................................................... 35 2.2. In-vivo laser lesion in the mouse ................................................................................ 35 2.3. Electrophysiology ....................................................................................................... 36 2.3.1. The patch clamp technique .............................................................................. 36 2.3.2. Acute slices preparation ................................................................................... 39 2.3.3. The patch clamp setup ..................................................................................... 39 2.3.4. Glass micropipettes production........................................................................ 40 2.3.5. Intracellular solutions....................................................................................... 40 2.3.6. Performing a patch clamp recording ................................................................ 40 2.3.7. Data acquisition ............................................................................................... 41 2.3.8. Design of the experiments ............................................................................... 42 1 Table of Contents 2.3.9. Isolation of excitatory and inhibitory postsynaptic currents ............................ 42 2.3.10. Stimulation protocols ....................................................................................... 43 2.3.11. Analysis of electrophysiological data .............................................................. 43 2.3.12. Drugs ................................................................................................................ 44 2.3.13. 7,8 DHF in vitro and in vivo treatment ............................................................ 44 2.4. Histology..................................................................................................................... 44 2.4.1. Nissl staining .................................................................................................... 44 2.5. BDNF quantification .................................................................................................. 45 2.6. Statistical analysis ....................................................................................................... 45 3. Results ................................................................................................................................ 47 3.1. Modulatory effects of the novel TrkB receptor agonist 7,8-Dihydroxyflavone on synaptic transmission and intrinsic neuronal excitability in vitro .............................. 47 3.1.1. 7,8-DHF depresses GABAergic transmission ................................................ 47 3.1.2. 7,8-DHF does not affect the glutamatergic transmission................................. 52 3.1.3. 7,8-DHF alters layer 2/3-pyramidal neurons intrinsic properties .................... 56 3.2. Modulatory effects of the novel TrkB receptor agonist 7,8-Dihydroxyflavone on synaptic transmission and intrinsic neuronal excitability in vivo ............................... 58 3.2.1. Chronic administration of 7,8-DHF reduces GABAA receptors-mediated mIPSCs frequency ............................................................................................... 58 3.2.2. Chronic administration of 7,8-DHF does not rescue the impairment of GABAergic transmission in BDNF (+/−) mice ................................................... 59 3.3. Lesion-induced alterations of GABAergic transmission in the visual cortex of WT and BDNF (+/−) mice ................................................................................................. 61 3.3.1. Histology of the lesion ..................................................................................... 61 3.3.2. Unaltered intrinsic properties of pyramidal neurons in layers 2/3 post-lesion 62 3.3.3. Lesion-induced effects on basal GABAergic synaptic transmission ............... 64 3.3.4. Increased Paired-Pulse ratio (PPR) post-lesion ............................................... 66 3.3.5. Effects of the lesion on eIPSCs ........................................................................ 68 3.3.6. The effects of the lesion on the GABAergic neurotransmission are mimicked by an acute block of the TrkB receptor ............................................................... 71 3.3.7. The lesion doe not reduce BDNF protein levels .............................................. 73 4. Discussion .......................................................................................................................... 75 4.1. Characterization of the pharmacological profile of the new TrkB receptor agonist 7,8-Dihydroxyflavone ................................................................................................. 75 4.1.1. In vitro 7,8-DHF effects on synaptic transmission and intrinsic neuronal excitability ........................................................................................................... 75 4.1.2. In vivo 7,8-DHF effects on GABAergic transmission in WT and BDNF (+/−) mice ..................................................................................................................... 79 4.2. Lesion-induced alterations of the GABAergic transmission in the visual cortex of WT and BDNF (+/−) mice .......................................................................................... 82 4.2.1. Lesion-induced effects on layer 2/3-pyramidal neurons intrinsic properties... 83 2 Table of Contents 4.2.2. Presynaptic functional properties of GABAergic synapses in shamand lesion- treated WT and BDNF (+/−) mice....................................................................... 83 4.2.3. Postsynaptic properties of GABAergic in sham and lesion-treated WT and BDNF (+/−) mice ................................................................................................ 85 4.2.4. Implication of the BDNF-TrkB signaling in the lesion-induced alterations of GABAergic transmission ..................................................................................... 89 5. Concluding remarks ..........................................................................................................

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    107 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us